Overview: Cyclosporine Level TestIntroduction: The Cyclosporine Level Test measures cyclosporine levels to monitor immunosuppressive therapy in transplant patients, helping prevent rejection or toxicity. Affecting 1 in 100 transplant patients annually, these issues pose diagnostic challenges due to narrow therapeutic range. Following 2023 American Society of Transplantation (AST) guidelines, it uses LC-MS/MS for high accuracy, supporting toxicology screening. This test is vital for monitoring, dose adjustment, and improving outcomes in transplant medicine.
Other Names: Cyclosporine Monitoring Test, Immunosuppressant Level Assay.
FDA Status: Laboratory-developed test (LDT), meeting toxicology standards for diagnostic reliability.
Historical Milestone: Drug level testing began in the 1980s with research by Kahan, who established cyclosporine monitoring. LC-MS/MS advancements in the 2000s by Waters improved detection, surpassing earlier HPLC methods.
Purpose: Measures cyclosporine concentration to monitor therapy, guides dose adjustment, and evaluates transplant patients, aiming to prevent rejection or toxicity.
Test Parameters: Cyclosporine concentration
Pretest Condition: No special preparation required. Collect whole blood. Report history of transplant.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document transplant history or immunosuppression. Include current medications or rejection signs.
Consent: Written consent required, detailing the test's purpose, toxicity risks (e.g., nephrotoxicity), and sample collection risks.
Procedural Considerations: Uses LC-MS/MS to measure cyclosporine, requiring labs with mass spectrometers. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Abnormal levels guide dose adjustment, preventing rejection or toxicity. Regular monitoring might improve graft survival, while untreated issues lead to failure. Normal levels suggest stability.
Specialist Consultation: Consult a transplant specialist for interpretation.
Additional Supporting Tests: Creatinine level, liver function test, or biopsy to confirm status.
Test Limitations: Specific to cyclosporine; correlation with clinical status needed. Variability in metabolism may occur.
References: AST Guidelines, 2023; Transplantation, Kahan BD, 2022.
